Literature DB >> 18388945

Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals.

Jung-Joon Min1, Vu H Nguyen, Hyun-Ju Kim, Yeongjin Hong, Hyon E Choy.   

Abstract

We describe a protocol for imaging bacterial luciferase (Lux)-expressing bacteria in small living animals. In this protocol, light emitted by Lux-expressing bacteria is detected and monitored by a cooled charge-coupled device detector. When these bacteria are administered to animals, it provides a potentially valuable approach to generate sensitive whole-body images with extremely low background. This imaging technology should enable the real-time monitoring of bacterial migration into both primary and metastatic tumors in several different mouse tumor models at a strong quantification power.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388945     DOI: 10.1038/nprot.2008.32

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  48 in total

1.  Dual-reporter Imaging and its Potential Application in Tracking Studies.

Authors:  Jie Ding; Chao Wang; Pei-Cheng Li; Zhen Zhao; Cheng Qian; Cong-Xiao Wang; Yu Cai; Gao-Jun Teng
Journal:  J Fluoresc       Date:  2016-01       Impact factor: 2.217

2.  Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI.

Authors:  Guanshu Liu; Chetan Bettegowda; Yuan Qiao; Verena Staedtke; Kannie W Y Chan; Renyuan Bai; Yuguo Li; Gregory J Riggins; Kenneth W Kinzler; Jeff W M Bulte; Michael T McMahon; Assaf A Gilad; Bert Vogelstein; Shibin Zhou; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2013-10-07       Impact factor: 4.668

3.  Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis.

Authors:  Don-Kyu Kim; Jae-Ho Jeong; Ji-Min Lee; Kwang Soo Kim; Seung-Hwan Park; Yong Deuk Kim; Minseob Koh; Minsang Shin; Yoon Seok Jung; Hyung-Seok Kim; Tae-Hoon Lee; Byung-Chul Oh; Jae Il Kim; Hwan Tae Park; Won-Il Jeong; Chul-Ho Lee; Seung Bum Park; Jung-Joon Min; Sook-In Jung; Seok-Yong Choi; Hyon E Choy; Hueng-Sik Choi
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

Review 4.  In vivo cell tracking with bioluminescence imaging.

Authors:  Jung Eun Kim; Senthilkumar Kalimuthu; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2014-11-26

5.  Remotely activated protein-producing nanoparticles.

Authors:  Avi Schroeder; Michael S Goldberg; Christian Kastrup; Yingxia Wang; Shan Jiang; Brian J Joseph; Christopher G Levins; Sneha T Kannan; Robert Langer; Daniel G Anderson
Journal:  Nano Lett       Date:  2012-05-08       Impact factor: 11.189

6.  Active matter therapeutics.

Authors:  Arijit Ghosh; Weinan Xu; Neha Gupta; David H Gracias
Journal:  Nano Today       Date:  2020-02-27       Impact factor: 20.722

7.  Engineering and visualization of bacteria for targeting infarcted myocardium.

Authors:  Uyenchi N Le; Hyung-Seok Kim; Jin-Sook Kwon; Mi Yeon Kim; Vu H Nguyen; Sheng Nan Jiang; Byeong-Il Lee; Yeongjin Hong; Myung Geun Shin; Joon Haeng Rhee; Hee-Seung Bom; Youngkeun Ahn; Sanjiv S Gambhir; Hyon E Choy; Jung-Joon Min
Journal:  Mol Ther       Date:  2011-03-01       Impact factor: 11.454

8.  Targeted deletion of the ara operon of Salmonella typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents.

Authors:  Hyun Hong; Daejin Lim; Geun-Joong Kim; Seung-Hwan Park; Hyeon Sik Kim; Yeongjin Hong; Hyon E Choy; Jung-Joon Min
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Attenuated Salmonella engineered with an apoptosis-inducing factor (AIF) eukaryotic expressing system enhances its anti-tumor effect in melanoma in vitro and in vivo.

Authors:  Huan Wang; Tingtao Chen; Linxi Wan; Jiachen Lu; Hong Wei; Ke-Yu Deng; Jing Wei; Hong-Bo Xin
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-24       Impact factor: 4.813

10.  Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy.

Authors:  Sheng-Nan Jiang; Thuy X Phan; Taek-Keun Nam; Vu H Nguyen; Hyung-Seok Kim; Hee-Seung Bom; Hyon E Choy; Yeongjin Hong; Jung-Joon Min
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.